Hello and welcome to another edition of The Weekly Dose!

Let's be real for a second. If you've lost weight on a GLP-1 medication — Mounjaro, Ozempic, Wegovy, or Zepbound — there's probably a quiet worry sitting in the back of your mind. What happens when I stop? What if I gain it all back?

That fear is valid. It's not anxiety spiraling out of control. It's not weakness. It's your brain picking up on something real — and the science backs it up completely.

But here's what nobody tells you: knowing why regain happens is the most powerful tool you have to prevent it. And most people are making a handful of completely avoidable mistakes that put them directly in its path. Today, we're breaking all of it down — the fear, the biology, and the four mistakes that matter most.

💡 Let's dive in!

📌 Here's what's inside this issue:
✅ Announcement: The Weekly Dose Community is LIVE!
✅ New: The Dose: Deep Dive Podcast — Episode 1 is out now!
✅Main Topic: The 4 Biggest Regain Mistakes GLP-1 Users Make (And How to Fix Them)
✅ Research Recap: New Study Links Protein-Rich Diets to Lower Dementia Risk in High-Risk Groups
✅ Question of the Week: What are you doing to protect your results from regain?

💊 Not on a GLP-1 yet — or looking for a more affordable path to access? Zealthy offers 100% online GLP-1 weight loss care, starting at just $39, with or without insurance. Over 200,000 prescriptions written. → Check your eligibility here

🎙️ NEW: The Dose: Deep Dive Podcast is LIVE — and Episode 1 is for you.

This is our monthly deep-dive series where we go beneath the surface of the scale on the topics that matter most to your GLP-1 journey.

Episode 1: How to Stop GLP-1 Muscle Loss

Are you losing weight — or are you losing your metabolic engine? Clinical data shows that up to 40% of weight lost on GLP-1s can come from lean muscle tissue. This debut episode breaks down exactly how to stop it:

🧠 The science of mechanotransduction — why your brain needs to be "convinced" to keep your muscle, and why a 20-minute kitchen workout beats an hour on the treadmill 🥩 The Protein Paradox — how to hit 0.7–1g per pound of goal body weight when you have zero appetite 🔄 Breaking the Plateau — why intermittent fasting may be sabotaging your progress, and how to use the "Architect Mindset" to restart your metabolism 💊 The Supplement Stack — the role of Creatine Monohydrate and Whey Isolate in maintaining cellular ATP and bypassing GI slowdown

Whether you're in your first week or your first year on a GLP-1 — this one's built for you.

👉 Listen now: https://www.theweeklydose.co/podcast/s/the_dose_deep_dive/how_to_stop_glp-1_muscle_loss

New deep dives drop monthly. Don't miss one. 🎧

Quick Reminder: The Weekly Dose Community is LIVE! If you've been waiting for a place to stay accountable, share progress, and connect with others on the GLP-1 journey — it's here.

Inside the Weekly Dose Skool Community, you'll find: 🏆 Weekly Wins — celebrate your progress and get inspired by others 📊 Accountability Challenges — small, sustainable goals to keep momentum 💬 Peer Support & Q&A — ask questions, get real feedback, share what's working 🎥 Expert Insights — resources and replays from trusted health pros

Whether you're on Mounjaro, Wegovy, Ozempic, Zepbound, or just starting out — this space was built for you.

👉 Join us here: https://www.skool.com/the-weekly-dose-8554/about

Let's keep showing up for ourselves — and for each other. 💪🚀

📌 Main Topic: The Fear of Regain After GLP-1s

Nobody hands you a playbook for what comes after the weight comes off. That gap — between the success and the sustainability — is exactly where most people get tripped up. And it's not because they're not motivated enough. It's because they're making a few specific, fixable mistakes.

Before we get into it, here's something that matters: none of these mistakes are your fault. The system — diet culture, short-term thinking, a medical field that historically undertreated obesity — sets most people up to stumble at this exact moment. These mistakes are common precisely because they make complete sense in the moment.

What it looks like: You hit your goal weight, decide it's time to come off the medication, and stop. Or maybe cost or side effects force the decision before you're ready. Either way — no tapering strategy, no provider conversation, no plan for what comes next.

Why it happens: Most of us are conditioned to think of medications as short-term interventions. "I'll take this until I reach my goal, then I'm done." That logic makes perfect sense for most medications. GLP-1s are different in a fundamentally important way.

The real cost: GLP-1 medications work by addressing the biological mechanisms of obesity — they reduce hunger hormones, regulate blood sugar response, and lower your metabolic set point. When you stop, the biology doesn't stay where you left it. It returns to baseline. In the STEP 4 trial, participants who discontinued semaglutide after an initial weight loss phase regained approximately two-thirds of their lost weight within 52 weeks (Rubino et al., JAMA, 2021). That is not a willpower failure. That is physiology doing exactly what physiology does.

The fix: Before you stop — or before cost forces the decision — have a real conversation with your provider. Ask about tapering options, maintenance dosing strategies, and what a structured transition plan looks like for you. Some people move to lower-frequency dosing rather than abrupt stops. For a deeper look at long-term management options, our Complete Guide to GLP-1 Side Effects is a solid starting point.

What it looks like: The appetite suppression is remarkable — you eat less, effortlessly. The scale moves. Life feels easier. Why would you change anything that isn't broken?

Why it happens: The medication genuinely does the heavy lifting, especially in the first six to twelve months. When something works this well, it feels almost counterproductive to add more effort on top of it.

The real cost: Here's the counterintuitive part. The medication created the conditions for change — but if you don't build new habits inside that window, you're not building anything that will hold you when the medication is gone. When you stop, appetite rebounds. Old biological patterns are still exactly where you left them. The result is a perfect storm for regain: the medication's effects disappear, but the old habits are right there waiting.

The fix: Think of your time on a GLP-1 as your metabolic window. You have a rare, impactful opportunity to build habits without the constant biological pull of hunger working against you. (This is a game-changer for many people who have struggled for years.) Use it. Start with one anchor habit: consistent protein at every meal, a 20-minute daily walk, or a consistent bedtime. These aren't bonuses. They're the foundation that holds your results after the medication is gone.

What it looks like: Mostly cardio — or no structured exercise at all because the weight is coming off anyway. Why add resistance training to the mix?

Why it happens: We've been trained to measure success by what the scale says. And muscle doesn't always show up on the scale — in fact, losing muscle can look exactly the same as losing fat when you're only watching the number. So we optimize for the wrong metric entirely.

The real cost: Muscle tissue is metabolically active — the more lean mass you carry, the more calories your body burns at rest. When weight loss on a GLP-1 includes significant muscle loss (which can happen without deliberate intervention), your resting metabolic rate drops. After stopping the medication, you're not just back to a baseline appetite — you're back to a baseline metabolism that is now less efficient. Regain doesn't just happen in this scenario. It accelerates.

The fix: Even two to three resistance training sessions per week makes a measurable difference in lean mass retention during a GLP-1 protocol. Pair that with adequate protein — most GLP-1 users benefit from targeting 0.7 to 1 gram of protein per pound of body weight daily. If appetite suppression makes hitting protein targets difficult, supplementing strategically is one of the most practical things you can do.

If you're looking for supplements that are specifically useful here, Thorne Creatine and Thorne Whey Protein Isolate are two that our community uses consistently. Creatine supports muscle strength and lean mass retention; protein helps fill the gap when appetite suppression makes hitting daily targets harder. Both are NSF Certified for quality.

→ Browse Thorne Creatine → Browse Thorne Protein

What it looks like: The worry creeps in. I've failed at every other diet. Why would this be different? I'll probably just gain it all back anyway. So you don't talk about it. You don't make a plan. You keep it quiet and hope for the best.

Why it happens: Diet culture has spent decades framing weight regain as a personal failing — a character flaw, not a biological reality. When the fear shows up, shame follows close behind. And shame is profoundly effective at keeping people silent and stuck.

The real cost: Unaddressed fear leads to avoidance. Avoiding your provider (when that relationship is actually your most powerful resource). Avoiding the scale (when early data gives you the most room to course-correct). Avoiding the community that could support you. Without accountability, regain can happen quietly — and slowly — until it's no longer quiet.

The fix: Name the fear out loud. Tell your provider. Share it in your community. The fear of regain is data — it tells you that what you've built matters to you, and that you're paying attention to the right things. That is a genuinely powerful starting place. Sound familiar? Then take the next step: write a simple "if-then" plan. "If I notice the scale moving up three pounds, I will do X." Specificity converts anxiety into action.

Each of these four mistakes shares a single common thread: treating the GLP-1 medication as the complete solution rather than the starting point. The medication is fundamentally, profoundly powerful — it can create conditions that diet and willpower alone cannot. But it works best as a scaffold. The habits, the lean muscle, the provider relationship, the community, and the plan are what you build while the scaffold is holding you up.

The fear of regain isn't a sign that GLP-1s don't work. It's a sign that what you've accomplished matters to you. That's something worth building on — deliberately, with a real strategy, starting today.

Ready to start or optimize your GLP-1 program?

🟢 Zealthy makes GLP-1 access simple — 100% online, prior auth support included, and plans starting at just $39. Most patients lose an average of 20% of their body weight in a year. → See if you qualify

💳 No insurance? No problem. Zealthy works with or without it. → Browse options

No insurance? Sesame Care offers transparent flat-rate GLP-1 visits — no hidden fees. → Browse pricing

We talk a lot in this community about protein — and for good reason. Your dietary habits on your GLP-1 journey have benefits that reach well beyond the scale.

A new study from Karolinska Institute, published in JAMA Network Open (Norgren et al., 2026), followed more than 2,100 adults aged 60 and older for up to 15 years. Researchers found that for people carrying the APOE 3/4 or 4/4 gene variants — which are linked to significantly higher Alzheimer's risk — higher intake of unprocessed meat was associated with notably slower cognitive decline and a lower risk of dementia. That elevated genetic risk was largely absent in the group that ate the most meat.

✔️ Among participants with high-risk APOE variants who ate lower amounts of meat, dementia risk was more than twice as high compared to those without these gene variants. ✔️ In high-risk participants who consumed the most meat, that elevated dementia risk was not observed — suggesting diet may meaningfully modify genetic risk. ✔️ The type of meat matters: a lower proportion of processed meat in total consumption was linked to lower dementia risk across all genetic groups, regardless of APOE variant.

For GLP-1 users, this research adds meaningful depth to why dietary quality matters. You're not just building protein habits to protect your weight loss — you may also be building habits that protect your cognitive health long-term. Choosing quality, unprocessed protein sources isn't only a macros decision. For a meaningful portion of the population, it's potentially a brain health decision too.

Want to read the full study? Read it here.

Research consistently documents significant regain after discontinuing GLP-1 medications. In the STEP 4 trial, participants who stopped semaglutide regained approximately two-thirds of their weight loss within 52 weeks (Rubino et al., JAMA, 2021). A 2025 systematic review and meta-analysis published in eClinicalMedicine (The Lancet) found that GLP-1 receptor agonist discontinuation was associated with a pooled mean weight regain of approximately 5.63 kg and 5.81% of body weight, though individual outcomes vary considerably based on lifestyle factors maintained during and after treatment.

It is primarily biological. Obesity is classified as a chronic condition with hormonal and metabolic underpinnings — GLP-1 medications address those mechanisms directly by reducing hunger hormones and regulating appetite signaling. When the medication stops, those mechanisms return to their pre-treatment state. The SURMOUNT-4 trial similarly documented that participants who stopped tirzepatide regained a substantial portion of lost weight within 52 weeks, not due to behavior change, but due to the underlying biology returning. Framing regain as a willpower failure is both inaccurate and counterproductive.

Current evidence points to three evidence-based strategies used together: (1) building consistent lifestyle habits — particularly resistance training and adequate protein intake — while still on the medication, before stopping; (2) working with your provider on a structured transition plan rather than stopping abruptly; and (3) maintaining community accountability or regular provider check-ins after stopping. A 2025 systematic review in Obesity Reviews (Berg et al.) found that discontinuation outcomes varied considerably based on lifestyle behaviors maintained alongside medication use.

Yes. Clinical evidence suggests that restarting a GLP-1 medication after a gap is effective for most people. The SURMOUNT-4 trial, which studied tirzepatide withdrawal and re-initiation, confirmed that weight loss response was preserved upon restarting. If cost, access, or side effects previously led to stopping, discussing these barriers directly with your provider is worthwhile — there may be dosing or access solutions that weren't available before.

What's the biggest thing you're doing — or wish you were doing — to protect your results from regain?

Here are a few to get you started — but don't let these limit you:

Or maybe it's something completely different. Hit reply and tell me — I read every single response, and the best answers get featured in next week's issue (with your permission, of course).

Your experience might be exactly what someone else needs to hear right now. 💪

📣 That's a Wrap! 💌 Enjoyed this issue?

Forward this email to a friend who might benefit!

If you didn't answer the Question of the Week above — now's your chance. Hit reply and share what's on your mind. I read every response.

📆 See you next week! — The Weekly Dose Team

⚠️ Some links in this post may be affiliate links. If you make a purchase, we may earn a commission at no extra cost to you. We only recommend products our community actually uses.